17.1 C
New Delhi
December 4, 2023
News Bridge

Rajnath Singh Releases DRDO’s Anti-Covid19 Drug 2-DG

Defence minister Rajnath Singh on Monday released the first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19.

The anti-COVID therapeutic application of the drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with Dr Reddy’s Laboratories (DRL) in Hyderabad.

Speaking on the occasion, the Defence Minister congratulated DRDO and DRL, Hyderabad for manufacturing the drug that will help the COVID patients to reduce oxygen dependency and recover quickly.

“The drug is a perfect example of the country’s scientific prowess and a milestone in the efforts towards self-reliance,” reads a statement issued by the Ministry of Defence.

“2-DG drug is a new ray of hope in these challenging times,” said Rajnath Singh, expressing confidence that the medicine will play a crucial role in winning the fight against COVID-19.

The drug comes in powder form in a sachet and is taken orally by dissolving it in water, the ministry said.


Related posts

Covid19 | Delhi, UP Extend Lockdown Till May 17, Metro Suspended


Congress’s Bharat Jodo Yatra Resumes From Kollam District In Kerala


Covid19: Record 2.34 Lakh Fresh Covid Cases In India, 1,341 Deaths In 24 Hours


WhatsApp Blinks In Stand-Off With Govt, Puts New Privacy Policy On Hold


Delhi Goes Into ‘Mini-Lockdown’ Till April 26 To Control Covid Infection


India-Russia Signs AK-203 Rifle Deal; 10 Years Military-Technical Cooperation


Leave a Comment